Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY NEWS
Company News      
Ajanta Pharma Ltd.
Change Company   
BSE Code 532331
ISIN Demat INE031B01049
Book Value 310.16
NSE Code AJANTPHARM
Dividend Yield % 1.07
Market Cap 326706.66
P/E 34.91
EPS 74.91
Face Value 2  
02-Sep-2025 Ajanta Pharma informs about analyst meet
29-Jul-2025 Ajanta Pharma informs about press release
18-Jul-2025 Ajanta Pharma informs about outcome of AGM
08-Jul-2025 Ajanta Pharma informs about certificate
19-Jun-2025 Ajanta Pharma informs about disclosure
17-Jun-2025 Ajanta Pharma informs about disclosure
12-May-2025 Ajanta Pharma informs about annual secretarial co...
05-May-2025 Ajanta Pharma informs about written transcript of...
02-May-2025 Ajanta Pharma informs about newspaper publication
21-Mar-2025 Ajanta Pharma to expand manufacturing capacity
20-Mar-2025 Ajanta Pharma informs about updates
11-Mar-2025 Ajanta Pharma informs about disclosure
14-Feb-2025 Ajanta Pharma informs about disclosure
07-Feb-2025 Ajanta Pharma informs about analyst meet
04-Feb-2025 Ajanta Pharma informs about clarification on mark...
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.